FDA to hold meeting on CAD fetal monitors

The FDA is seeking feedback on evaluating and improving the effectiveness of fetal monitors that use computer-aided detection (CAD) technology.

To evaluate the technology, the agency is holding a free all-day workshop on the subject on Nov. 10 at its Silver Spring, Md., campus.

Attendees will discuss how to identify and differentiate the various categories of the devices and the corresponding levels of evidence needed to validate them. Participants also will discuss how current databases might be used to verify and validate algorithms for the devices.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.